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Abstract
The microtubule cytoskeleton provides essential structural support for all eukaryotic cells and can be assembled into various
higher order structures that perform drastically different functions. Understanding how microtubule-containing assemblies
are built in a spatially and temporally controlled manner is therefore fundamental to understanding cell physiology.
Toxoplasma gondii, a protozoan parasite, contains at least five distinct tubulin-containing structures, the spindle pole,
centrioles, cortical microtubules, the conoid, and the intra-conoid microtubules. How these five structurally and functionally
distinct sets of tubulin containing structures are constructed and maintained in the same cell is an intriguing problem.
Previously, we performed a proteomic analysis of the T. gondii apical complex, a cytoskeletal complex located at the apical
end of the parasite that is composed of the conoid, three ring-like structures, and the two short intra-conoid microtubules.
Here we report the characterization of one of the proteins identified in that analysis, TgICMAP1. We show that TgICMAP1 is
a novel microtubule binding protein that can directly bind to microtubules in vitro and stabilizes microtubules when
ectopically expressed in mammalian cells. Interestingly, in T. gondii, TgICMAP1 preferentially binds to the intra-conoid
microtubules, providing us the first molecular tool to investigate the intra-conoid microtubule assembly process during
daughter construction.
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Introduction
The microtubule (MT) cytoskeleton provides structural support
for vital functions such as cell motility, cell division, and material
flow in eukaryotic cells. A MT is a polymer with distinct polarity,
where each MT subunit, i.e. alpha and beta tubulin heterodimer,
is placed in the same orientation in the polymer, resulting in two
ends (minus and plus ends) that have different structure and
assembly dynamics. Higher order structures formed by MT and
MT-binding proteins perform drastically different functions such
as flagella beating, chromosome alignment and segregation, and
vesicular transport. Understanding how MT-containing assemblies
are built in a spatially and temporally controlled manner is
fundamental to understanding cell physiology.
Toxoplasma gondii is a fantastic cell biological model organism for
studying the biogenesis of tubulin containing structures. It has a
strictly reproducible shape, defined by a highly ordered cytoskel-
eton maintained precisely through generations. The ultrastructure
of T. gondii cytoskeleton is very well characterized [1–7]. The
cytoskeleton of every single parasite in a population contains
exactly 22 cortical MTs, one basal complex, and one apical
complex made of three ring structures, 14 filaments of a novel
tubulin polymer (collectively termed ‘‘the conoid’’) [7], and two
intra-conoid MTs. There are at least five distinct tubulin-
containing structures within T. gondii (Figure 1). Besides the
conoid, intra-conoid MTs, and cortical MTs, MTs are also
assembled into two other structures: spindle poles, which organize
the intra-nucleus spindle during parasite replication, and centri-
oles, which contain a central single MT and nine outer single MTs
[4]. This MT organization of the centrioles is distinct from the
centrioles of higher eukaryotes that are composed of two central
MTs and nine triplet peripheral MTs. The parasite also contains
another novel cytoskeletal structure, termed the basal complex, at
its basal end [6,8]. The basal complex contains a number of
putative MT binding proteins such as dynein light chain and
centrin 2, but no tubulin based structures have been observed in
the basal complex.
How T. gondii constructs and maintains the five structurally and
functionally distinct sets of tubulin containing structures in the
same cell is an intriguing problem. For example, both the intra-
conoid MTs and cortical MTs are canonical MTs with 13
protofilaments; however, their localization and length are very
different. The 22 cortical MTs originate from a ring like structure
at the distal end of the apical complex, and extend for ,5 mm, or
,2/3 of the parasite body [1,3,4,7]. The two intra-conoid MTs,
however, do not have an obvious organizing center. They are
positioned close to the center of the apical complex, and only
about 0.4 mm in length. CryoEM studies show that both sets of
MTs are heavily decorated with MT binding proteins with quite
different association patterns [1,7]. The identification and
characterization of MT binding proteins, therefore, is key to
understanding the construction and functions of these various
MT-containing assemblies. Finally, any new knowledge concern-
ing T. gondii cytoskeleton is particularly welcome, as T. gondii is
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is the most common cause of congenital neurological defects in
humans [9]. It also causes devastating opportunistic infections in
immuno-compromised patients [10]. Many of its 5,000 relatives
in phylum Apicomplexa are also important human or animal
pathogens [11], including Plasmodium spp, which kills more than a
million people every year. The damage caused by T. gondii,m o s t
commonly severe lytic cerebral and ocular lesions, absolutely
depends on its ability to replicate [10,12–14]. In the absence of
massive, uncontrolled expansion of the parasite population, the
infections are benign [15–17]. The MT-based T. gondii cytoskel-
eton is essential for parasite survival and proliferation, as it
provides the framework for organelle replication and partition. In
addition, it is likely to be important for parasite invasion. The
intra-conoid MTs, for example, are closely associated with the
secretory organelles, such as rhoptries and micronemes, and are
speculated to provide structural support for protein secretion
from these organelles during invasion [3,18]. As tubulins
themselves are highly conserved between T. gondii and mamma-
lian cells [19], novel MT binding proteins in T. gondii are prime
drug targets.
Here we report the identification and characterization of a novel
T. gondii MT binding protein, intra-conoid microtubule associated
protein1 (TgICMAP1, Accession number: TgME49_039300).
TgICMAP1 is a large 135 kDa protein that contains a coiled-coil
Structural Maintenance of Chromosomes (SMC)-like domain.
Purified recombinant eGFP-TgICMAP1 protein binds to in vitro
polymerized MTs, suggesting that its interaction with the MT
is direct. Surprisingly, in T. gondii, TgICMAP1 preferentially binds
to the intra-conoid MTs. When over-expressed in mammalian
cells, eGFP-TgICMAP1 coats and stabilizes MTs, suggesting that
TgICMAP1 might play a role in stabilizing the intra-conoid MTs.
The discovery of TgICMAP1 thus provides us the first molecular
tool to dissect the function and the assembly pathway of the intra-
conoid MTs.
Results
TgICMAP1 is a coiled-coil protein that binds to and
stabilizes MTs when ectopically expressed in mammalian
cells
Despite the richness of novel tubulin containing structures in T.
gondii, only a few MT binding proteins have been identified in T.
gondii [6]. Previously, we identified ,170 proteins in the apical
complex of T. gondii using comparative proteomics [6]. To quickly
assess if any of the novel proteins could interact with MTs, eGFP
fusions of a number of these proteins were constructed and
expressed in mammalian cells. One of the proteins tested,
designated TgICMAP1, showed binding along the lattice of
MTs (Figure 2). TgICMAP1 is likely to have a high affinity for
MTs, as heavy eGFP-TgICMAP1 coating correlated with much
weaker anti-tubulin staining when compared with that of uncoated
MT segments, suggesting that perhaps TgICMAP1 binding blocks
the accessibility of tubulin antibody to the MTs (Figure 2, insets).
To determine if TgICMAP1 homologues are present in other
protozoan parasites species, the TgICMAP1 protein sequence was
blasted against the available apicomplexan parasite genomic
sequences (http://eupathdb.org/eupathdb/), including those of
Plasmodium spp, Cryptosporidium spp, Theileria spp, and Neospora caninum.
The search revealed a single homologue in one of the closest
relatives of T. gondii, Neospora caninum, another parasite that belongs
to the family of Sarcocystidae. Neospora ICMAP1 (NcICMAP1,
Accession Number: Nc_LIV_ 070470) shares 82% identity and
89% similarity with TgICMAP1 (Figure S1).
Approximately 50% of TgICMAP1 was predicted to form
coiled-coil domains by coiled-coil domain prediction software
(Figure 3A) [20]. When blasted against the NCBI non-redundant
protein database, the sequence from amino acids 200 to 475 in
TgICMAP1 was recognized to be homologous to the coiled-coil
region in Structural Maintenance of Chromosomes (SMC)
domains (EValue=4e
-09) (Figure 3B and S1) [21–26]. The
Figure 1. Schematic drawings of T. gondii (Adapted from [6]). Left and middle: a longitudinal section and a semitransparent projected view of
the cytoskeleton of a dividing cell. Right: an enlarged view of the apical portion of the cytoskeleton. The cytoskeleton of T. gondii includes the apical
and the basal complexes, and the cortical cytoskeleton, which contains the cortical MTs, and the Inner Membrane Complex (IMC), a set of flattened
vesicles with an underlying filamentous protein network. The centrioles/spindle pole assembly is located close to the nucleus and is not shown in the
drawings. The apical complex is formed of the conoid, the intra-conoid MTs and three ring-like structures. The conoid fibers are novel tubulin
polymers, the structure of which is dramatically different from that of a canonical MT, such as the cortical MTs and the intra-conoid MTs. In the
enlarged view of the apical portion of the cytoskeleton (right), EM cross-sections of a single conoid fiber and a canonical MT are shown.
doi:10.1371/journal.pone.0007406.g001
Characterization of TgICMAP1
PLoS ONE | www.plosone.org 2 October 2009 | Volume 4 | Issue 10 | e7406Figure 2. eGFP-TgICMAP1 coats MTs when ectopically expressed in mammalian cells. Images of mouse embryonic fibroblast cells
transiently expressing eGFP-TgICMAP1 (green) labeled with anti-tubulin YL1/2 (red), which show that eGFP-TgICMAP1 binds to a subset of MTs,
mainly around the nucleus. Insets: notice that MT segments labeled by eGFP-TgICMAP1 tend to have much weaker staining of tubulin antibody than
adjacent segments (arrowheads and brackets). Images are projections of deconvolved 3-D stacks. Insets are single optical sections of indicated
regions in images and are at 26magnification.
doi:10.1371/journal.pone.0007406.g002
Figure 3. TgICMAP1 is a coiled-coil protein and contains a SMC-like coiled-coil domain. (A) Graphic display of predicted coiled-coil domains in
TgICMAP1. Y-axis,probabilityof formation of coiled-coil domain wherevalues closeto1 indicateregionswitha high propensitytoform coiled-coil domains.
X-axis, TgICMAP1 amino acids. (B) Schematics of full-length TgICMAP1 and the two TgICMAP1 truncation proteins, TgICMAP1
1–474 and TgICMAP1
455–1231.
doi:10.1371/journal.pone.0007406.g003
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but the presence of the coiled-coil region in the SMC domain
internal to TgICMAP1 may suggest anti-parallel dimerization of
this molecule through intermolecular association [21].
When expressed at a high level, eGFP-TgICMAP1 colocalizes
with perinuclear MTs (Figure 2). To determine if there is any
correlation between TgICMAP1 binding and tubulin post-transla-
tional modifications, immunofluorescence experiments with anti-
acetylated tubulin antibodies were performed. Analysis showed that
MTs that were heavily coated with eGFP-TgICMAP1 were also
acetylated (Figure 4A). Since acetylation is often a marker for stable
MTs [27–29], we wanted to directly test if the binding of eGFP-
TgICMAP1 indeed increases MT stability. Upon treatment with
2 mMnocodazole forfourhours,62%ofHeLacellstransfectedwith
eGFP-TgICMAP1 still contained high levels of MTs, significantly
higher than that of untransfected cells on the same slide, which was
28% (p,0.01) (Figure 4, B and C). High eGFP-TgICMAP1
expression level accentuated this effect, as 86% of cells expressing
highlevel of eGFP-TgICMAP1 (defined by fluorescence levels three
times greater than that of untransfected cells) contained significant
amount of MTs (p,0.001) (Figure 4, B and C).
TgICMAP1 binds MTs in vitro
The fact that a T. gondii protein can bind to MTs in a ‘‘foreign’’
environment, the cytosol of mammalian cells, suggests that
TgICMAP1 likely binds to the MTs directly rather than through
other MT binding proteins. To determine if the interaction
between TgICMAP1 and MTs is indeed direct, recombinant
6xHis-eGFP-TgICMAP1 was expressed and purified from E. coli,
and incubated with in vitro polymerized MTs stabilized with the
GTP analog GMPcPP. The 6xHis-eGFP-TgICMAP1 and MT
suspension was then spun onto coverslips and MTs were visualized
by staining with anti-tubulin antibody (Figure 5A). TgICMAP1
showed binding along the MT lattice. No MT binding was
observed in the negative control sample, where 6xHis-eGFP [30]
was used in place of 6xHis-eGFP-TgICMAP1 (Figure 5B).
TgICMAP1 preferentially localizes to the intra-conoid MTs
in T. gondii
Despite its ability to bind MT directly, TgICMAP1 only binds
to a subset of tubulin containing structures in T. gondii.
Colocalization studies showed that eGFP-TgICMAP1 predomi-
nately localized to a thin focal point at the apical end of the
parasite (Figure 6A), much narrower in width when compared to
that of the conoid, marked by co-expression of mCherryFP-
TubA1 in the same cell. eGFP-TgICMAP1 also localized to the
centriole/spindle pole area (arrows) (also marked by the expression
of mCherryFP-TubA1 [8]), although the intensity of this labeling
varied depending on the expression level of eGFP-TgICMAP1. To
investigate the localization of endogenous TgICMAP1, an anti-
TgICMAP1 antibody was produced (Figure 6B–F). Immunoflu-
orescence assays using the anti-TgICMAP1 antibody confirmed
that endogenous TgICMAP1 had similar apical localization as
eGFP-TgICMAP1 in the apical complex, but a specific localiza-
tion in the centriole/spindle pole area could not be confirmed
(Figure 6B). By Western blot, the anti-TgICMAP1 antibody
Figure 4. Ectopically expressed eGFP-TgICMAP1 stabilizes MTs in mammalian cells. (A) eGFP-TgICMAP1 transfected cells (green) labeled
with rat anti-tubulin YL1/2 antibody (red) and mouse anti-acetylated tubulin antibody (cyan). eGFP-TgICMAP1 coated MTs display higher acetylation
level compared with adjacent ‘‘uncoated’’ MTs (insets). Insets are at 26magnification. Scale bar=10 mm. (B) Graph showing the mean percentages of
untransfected (blue bar, ‘‘untransfected’’); eGFP-TgICMAP1 transfected (green bar, ‘‘transfected’’); low (yellow bar) and high (dark green bar) eGFP-
TgICMAP1 expressing HeLa cells containing high levels of MTs after nocadazole treatment. The error bars indicate standard error of the mean (SEM).
‘‘*’’ : p,0.01, ‘‘**’’: p,0.001. (C) Representative images of untransfected and transfected cells expressing low and high levels of eGFP-TgICMAP1 after
nocodazole treatment. Scale bar=10 mm.
doi:10.1371/journal.pone.0007406.g004
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predicted size of TgICMAP1 (Figure 6C). We do not know why
TgICMAP1 ran as a doublet in reducing SDS-PAGE, but post-
translational modification is a potential cause, and we are
currently investigating this possibility.
Because the conoid and the intra-conoid MTs are the only
tubulin containing structures in the apical complex (Figure 1) [3],
the highly restricted localization of TgICMAP1 in the apical
complex strongly suggests that TgICMAP1 binds to the intra-
conoid MTs. This was confirmed by electron microscopy, where
the intra-conoid MTs were decorated with gold particles
indicating the binding of anti-TgICMAP1 antibody (Figure 6D).
Consistent with our previous experience in immunolabeling
apical complex proteins, where antigen accessibility was often an
issue [7], harsh extraction conditions were needed for the successful
labeling of the intra-conoid MTs with the anti-TgICMAP1
antibody. For extracellular parasites we found that 10 mM
deoxycholate extraction gave the best labeling of the intra-conoid
MTs with the anti-TgICMAP1 antibody (Figure 6, E and F,
arrows). This condition often resulted in the loss of the banana-like
shape of the parasite, likely due to the release of the cortical MTs
from other parasite membrane-cytoskeletal elements (Figure 6E).
However in cases where the basal end of the parasite held together,
we were surprised to find anti-tubulin staining in a ring-like
structure at the basal end of the parasite (Figure 6F, arrowhead).
This is the first time that a tubulin containing structure has been
observed at the basal end of the parasite. Recently, another group
has also made a similar observation independently (Personal
communication, Louis Weiss, Albert Einstein College, NY).
The first 474 amino acids of TgICMAP1 are important for
intra-conoid MT association in the parasite
To determine if the SMC containing N-terminal domain is
important for MT binding, we made eGFP fusions of two TgICMAP1
truncation mutants and expressed them in T. gondii:e G F P -
TgICMAP1
1–474, a N-terminal truncation that contains the SMC-
like coiled-coil domain, and eGFP-TgICMAP1
455–1231, a C-terminal
truncation that excludes most of the SMC-like domain (c.f. Figure 3B).
Expression of eGFP-TgICMAP1
1–474 recapitulated the intra-conoid
MT localization of the full-length protein at the apical complex with,
however, more prominent cytoplasmic pool localization (Figure 7A–B).
Interestingly, eGFP-TgICMAP1
1–474 also displayed basal complex
labeling (Figure 7B, inset). In contrast, deletion of the SMC-like
domain in eGFP-TgICMAP1
455–1231 resulted in the complete loss of
apical complex localization, with the truncated protein predominantly
localizing to the nucleus (Figure 7C). Together, these data show that
the first 474 amino acids of TgICMAP1 are essential for the intra-
conoid MT association in T. gondii. The role of the C-terminus is less
clear,but may be important for regulating the efficiency of TgICMAP1
targeting to the apical complex or may affect the binding affinity of
TgICMAP1 for MTs.
TgICMAP1 is a marker for monitoring the intra-conoid MT
construction process during daughter formation
The apical complex is a highly intricate, motile cytoskeletal
machine that is likely to be important in parasite invasion and
replication [6]. Therefore, how the different parts of this machine
are assembled together during daughter cell construction is of great
interest. Dueto the lack of EMevidence and appropriate markers, it
is not known whether the two intra-conoid MTs are assembled into
the apical complex when the daughters are still being constructed
inside the mother or after the daughters have emerged from the
mother and become independent entities. TgICMAP1, the first
marker for the intra-conoid MTs, allowed us to address this
question. Figure 8 shows the localization of eGFP-TgICMAP1 in a
dividing parasite (green), where both the mother and two daughter
cortical profiles were marked by an antibody recognizing IMC1
(red), a component of a protein meshwork underlying the parasite
Figure 5. TgICMAP1 binds MTs in vitro. Recombinant 6xHis-eGFP-TgICMAP1 (green) (A) or 6xHis-eGFP (B) (green) were incubated with in vitro
polymerized MTs, spun onto coverslips, and stained with mouse-anti-tubulin B-5-1-2 (red). 6xHis GFP-TgICMAP1 protein bound along the MT lattice.
No MT binding was observed in 6xHis-eGFP control samples. Scale bars=10 mm.
doi:10.1371/journal.pone.0007406.g005
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PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7406Figure 6. TgICMAP1 localizes to the intra-conoid MTs in T. gondii. (A) In T. gondii, eGFP-TgICMAP1 (green) localized to the apical complex of
the parasite (inset), in a region narrower than the width of the conoid marked by mCherryFP-TubA1 (red). eGFP-TgICMAP1 also labeled the centriole/
spindle pole area, which also incorporated mCherryFP-TubA1 (arrows). Inset is at 36 magnification. Scale bar=2 mm. (B) Images of a parasite
expressing mCherryFP-TubA1 (red) fixed and permeablized with methanol and labeled with anti-TgICMAP1 (green) show the prominent apical
complex localization of endogenous TgICMAP1, which is similar to that of eGFP-TgICMAP1, but a specific localization in the centriole/spindle pole
area could not be confirmed. The punctate labeling in the parasite body is likely to be the combined result of labeling for TgICMAP1 in the
cytoplasmic pool and non-specific labeling, as some spots are seen outside the parasite. Inset is at 36magnification. Scale bar=2 mm. (C) Western
blot of T. gondii total cell lysate showing that anti-TgICMAP1 antibody recognizes a ,135 kDa protein doublet (arrowheads) consistent with the
predicted size of TgICMAP1. The blot was stripped and reprobed with mouse-anti-tubulin B-5-1-2 to use a-tubulin as a loading control. (D) Left: Two
EM images of Ca
2+ ionophore–treated, deoxycholate-extracted RH parasites, which were immunogold-labeled with anti-TgICMAP1 antibody and
negatively stained with phosphotungstic acid. Scale bars=0.5 mm. Middle: Higher magnification of the apical complex regions of the parasites shown
in left panels, showing that the intra-conoid MTs (arrows and arrowheads) are decorated with gold particles, recapitulating the distribution of
fluorescence in Figure 6 A and B. Scale bars=0.2 mm. Right: schematic diagram of the T. gondii apical complex. (E and F) Parasites were extracted with
deoxycholic acid, and subsequently fixed and stained with anti-tubulin B-5-1-2 (red) and anti-TgICMAP1 (green). The cortical cytoskeleton of the
parasite in E was mostly destroyed with the cortical MTs splaying around the apical complex (white arrow). In (F) the cortical cytoskeleton of the
parasite was more intact and a ring-like structure stained with anti-tubulin antibody can be observed at the basal end of the parasite (red
arrowheads). Scale bars=2 mm.
doi:10.1371/journal.pone.0007406.g006
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MTs, eGFP-TgICMAP1 was localized to the daughter intra-conoid
MTs and the duplicated centriole/spindle pole assembly. There-
fore, the daughter intra-conoid MTs are present in the daughter
parasites as they are formed within the mother.
Discussion
Unlike mammalian cells in culture where the majority of the
MTs in the cell are highly dynamic, the tubulin containing
structures in T. gondii are extraordinarily stable in interphase
parasites. The apical complex and the cortical MTs, for example,
remain intact after harsh detergent extractions (c.f. Figure 6D–F)
[1,3,7] and are highly resistant to MT depolymerization drugs
such as oryzalin and nocodazole [5]. The stability of these tubulin
containing structures provides stiffness to the parasite cortex, thus
they are important in maintaining the parasite shape and are likely
to be important for basic parasite functions such as directional
movement and invasion. MT binding proteins are central players
in regulating MT stability and function. In this work, we report the
Figure 7. The first 474 amino acids of TgICMAP1 are important for intra-conoid MT association in T. gondii. Interphase parasites
expressing eGFP fusions (green) of full-length TgICMAP1 (A), TgICMAP1
1–474 (B), and TgICMAP1
455–1231 (C) were labeled with anti-IMC1 antibody (red).
EGFP-TgICMAP1
1–474 is localized to the intra-conoid MTs (green arrows). However, it displays stronger localization to the basal complex (inset)i n
comparison to eGFP-TgICMAP1. Its cytoplasmic pool is also more prominent than that of eGFP-TgICMAP1. eGFP -TgICMAP1
455–1231 is localized
predominantly to the nucleus and cytosol. The insets are at 2.56magnification. Scale bars=2 mm.
doi:10.1371/journal.pone.0007406.g007
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TgICMAP1, which is localized predominantly to the intra-conoid
MTs 2 two highly stable MTs in the apical complex. When
TgICMAP1 was ectopically expressed in mammalian cells, it
significantly increased the resistance of MTs to nocodazole
treatment, suggesting that TgICMAP1 might play a role in
stabilizing the two intra-conoid MTs. We also found colocalization
of TgICMAP1 with perinuclear MTs when TgICMAP1 was
expressed at a high level in mammalian cells. It has been shown
that perinculear MTs are more stable than other MTs, but it is
unclear if their perinuclear localization is the cause or the
consequence of their stability [34–36]. The colocalization of
TgICMAP1 with this subset of MTs therefore could be due to the
preference of TgICMAP1 in binding to these MTs (recognizing,
for example, certain distinct biochemical or structural properties of
these MTs) or an indirect result of the stabilization effect of
TgICMAP1 on MTs. Right now we cannot distinguish between
these two possibilities.
TgICMAP1 binds directly to the lattice of bare MTs
polymerized in vitro, yet in T. gondii it preferentially binds to the
intra-conoid MTs but not other tubulin containing structures, such
as the conoid and the cortical MTs. How is this specific binding
regulated? We showed previously that the conoid fibers are formed
of protofilaments arranged in a ‘‘comma’’ like structure much
different from that of a canonical MT [7] (c.f. Figure 1). This
drastic structural difference between the conoid fibers and the
intra-conoid MTs could well be the reason that TgICMAP1 is not
found in the conoid. This cannot explain however, why
TgICMAP1 does not bind to the cortical MTs, which are tubes
with 13 protofilaments, just like the intra-conoid MTs. We
speculate that the ‘‘masking’’ of the cortical MTs by other MT
binding proteins might play a role in excluding TgICMAP1 from
the cortical MTs. A second possibility is that differences in the
post-translational modifications of tubulin in the intra-conoid MTs
and the cortical MTs may affect the affinity of TgICMAP1
binding. In mammalian cells, for example, a number of MT-
binding proteins and molecular motors preferentially bind
detyrosinated MTs [37–41]. The identification of other proteins
that are specifically localized to the intra-conoid MTs or the
cortical MTs is necessary to test these hypotheses.
Protein secretion through the apical complex from the
membrane-bound invasion organelles, rhoptries and micronemes,
is essentialforparasite invasion into thehost cell [42–45].MTbased
cytoskeleton mediates the majority of vesicle traffic in eukaryotic
cells [46–49]. Based on electron microscopy evidence, it was
proposed that the intra-conoid MTs might serve as tracks for the
secretion of proteins from the apical complex during T. gondii
invasion [3,18]. Indeed, the length and position of the intra-conoid
MTs are very consistent with their potential structural roles in
secretion and the subsequent recycling of the lipid and proteins on
the membrane of the emptied vesicles. However, due to the lack of
knowledge of their protein composition other than tubulin, little is
known about how the intra-conoid MTs function and how they are
constructed during daughter formation. Using TgICMAP1 as a
marker for the intra-conoid MTs, we showed that the intra-conoid
MTs are formed during daughter parasite construction within the
mother parasite. In addition, we noted that the anti-TgICMAP1
antibody recognized a doublet by Western blot, which may suggest
that TgICMAP1 is post-translationally modified. Protein modifica-
tions, such as phosphorylation, have been shown to regulate the
binding of MT-associated proteins to MT in vertebrates [50].
Therefore, it will be very interesting to elucidate whether
TgICMAP1 is post-translationally modified, and understand
whether such modification regulates TgICMAP1 function.
TgICMAP1 is the first molecular tool that can be used to dissect
the biogenesis of the intra-conoid MTs. Future functional studies of
TgICMAP1, such as the creation of TgICMAP1 deficient parasites
and dominant negative mutants of TgICMAP1 will allow us to
specifically interfere with the function of the intra-conoid MTs to
understand the role of these two short MTs in the life of T. gondii.
Materials and Methods
Mammalian cell culture and transfection
HeLa cells were grown in DMEM (Cat#10569, Invitrogen,
CA) containing 10% (v/v) Hyclone Bovine Calf Serum (BCS)
(Cat#SH30087.03, Fisher Scientific, PA) and 1x antibiotic-
antimycotic (Cat#15240, Invitrogen) at 37uC and 5% CO2.
DNA (1 mg/well) was transfected into subconfluent HeLa cell
monolayers grown in six well plates by FuGene6 transfection
reagent (Cat #11815091001, Roche, IN) at a FuGene:DNA ratio
of 3:1 per manufacturer’s instruction.
Parasite culture and transfection
T. gondii RH tachyzoites were used in all experiments. The
parasites were maintained by continuous passage in human
Figure 8. Daughter intra-conoid MTs are assembled during daughter formation within the mother cell. eGFP-TgICMAP1 expression
(green) and anti-IMC1 staining (red) in a dividing parasite show that eGFP-TgICMAP1 is present at the intra-conoid MTs of both the mother (green
arrow) and the daughter parasites (green arrowhead) as well as the duplicated centriole/spindle pole assembly (white arrowheads). Scale bar=2 mm.
doi:10.1371/journal.pone.0007406.g008
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T. gondii transfection, 30–40 mg of DNA was electroporated into
1610
7 extracellular parasites suspended in DMEM with 1% BCS.
Electroporation was performed using a Harvard Apparatus BTX-
BCM630 electroporator (Holliston, MA,) with the electroporation
voltage set at 1480 V, capacitance set at 50 mF, and resistance set
at 25 V.
Construction of TgICMAP1 expression plasmids
1. T. gondii expression plasmids. For the construction of
pmin-eGFP-TgICMAP1, the TgICMAP1 coding region was
amplified from the RH cDNA library (obtained as previously
described [6]) using S124 and A125 primers (Table S1) digested
with BamHI and AflII, and subcloned into pmin-eGFP-TgDLC
plasmid [6] replacing the TgDLC/BglII-AflII fragment. The
BamHI and BglII ligation created a sequence that cannot be re-cut
by either BglII or BamHI. To introduce a unique BamHI site
between the eGFP and TgICMAP1 for subsequent subcloning, a
BamHI site downstream of the TgICMAP1 coding sequence on
pmin-eGFP-TgICMAP1 was first removed by replacing the
fragment between AflII and NotI sites with a PCR product
amplified from pmin-eGFP-TgICMAP1 using PCR mutagenesis
by overlap extension with primers S555, A555, S556, and A556
(Table S1). This resulted in the plasmid pmin-eGFP-TgICMAP1-
minus-BamHI. A BamHI site is then created between eGFP and
TgICMAP1 by replacing the fragment between NheI and NcoI
sites in pmin-eGFP-TgICMAP1-minus-BamHI with a PCR
product amplified from pmin-eGFP-TgICMAP1-minus-BamHI
using PCR mutagenesis by overlap extension with primers
S574, A574, S575, and A575 (Table S1). This resulted in the
plasmid pmin-eGFP-TgICMAP1-BamHI-linker. The construction
of pmin-eGFP-TgICMAP1-minus-BamHI and pmin-eGFP-
TgICMAP1-BamHI-linker was carried out by Biomeans Inc.
(Sugar Land, TX). pmin-eGFP-TgICMAP1
1–474 was constructed
by replacing eGFP-TgDLC/NheI-AflII in pmin-eGFP-TgDLC
with eGFP-TgICMAP1
1–474/NheI-HindIII from pc22-eGFP-
TgICMAP1
1–474 (see below). AflII and HindIII sites were filled-
in by Klenow fragment before the ligation. pmin-eGFP-
TgICMAP1
455–1231 was constructed by replacing TgICMAP1/
BamHI-AflII in pmin-eGFP-TgICMAP1-BamHI-linker with
TgICMAP1
455–1231/BamHI-AflII from pQE30-His-FLAG-
eGFP-TgICMAP1
455–1231 (see below).
2. Bacterial expression plasmids. To generate a bacterial
expression plasmid that has compatible sites with T. gondii
expression plasmids, AflII and NheI sites were introduced into
pQE30-DIP13 (a kind gift from Dr. Wolfgang Mages, Universita ¨t
Regensburg, Germany) in two steps. First, an AflII site was
introduced downstream of DIP13 by replacing the fragment
between HindIII and PvuII in PQE30-DIP13 with a PCR product
amplified from pQE30-DIP13 using PCR mutagenesis by overlap
extension with primers S552, A552, S553, A553, S554, and A554
(Table S1). This resulted in the plasmid pQE30-DIP13_AflII.
Second, a NheI site was introduced upstream of DIP13 by
replacing the fragment between EcoRI and HindIII in pQE30-
DIP13_AflII with a PCR product amplified from pQE30-
DIP13_AflII using PCR mutagenesis by overlap extension with
primers S552, A552, S576, and A576 (Table S1). This resulted in
the plasmid pQE30-DIP13_AflII-NheI. The construction of
pQE30-DIP13-AflII and pQE30-DIP13_AflII-NheI was carried
out by Biomeans Inc. pQE30-6xHis-eGFP-TgICMAP1
1–474 was
constructed by replacing DIP13/NheI-HindIII in pQE30-
DIP13_AflII-NheI with eGFP-TgICMAP1
1–474/NheI-HindIII
from pmin-eGFP-TgICMAP1-BamHI-linker. pQE30-6xHis-
eGFP-TgICMAP1 was constructed by replacing DIP13/NheI-
AflII in pQE30-DIP13_AflII-NheI with eGFP-TgICMAP1/NheI-
AflII from pmin-eGFP-TgICMAP1-BamHI-linker. A FLAG tag
was then introduced by amplifying a portion of the pQE30-6xHis-
eGFP-TgICMAP1
1–474 plasmid with primers pQE30 Forward
and His-FLAG-NheI-AS (Table S1). The PCR product was
digested with EcoRI and NheI and ligated into pQE30-His-eGFP-
TgICMAP1
1–474_EcoRI-NheI to form pQE30-6xHis-FLAG-
eGFP-TgICMAP1
1–474. To construct pQE30-His-FLAG-eGFP-
TgICMAP1
455–1231, TgICMAP1
455–1231 was first amplified by
PCR using pQE30-6xHis-eGFP-TgICMAP1 as a template and
primers BamHI-TgICMAP1C-S and AflII-TgICMAP1C-AS
(Table S1). The PCR product and pQE30-His-FLAG-eGFP-
TgICMAP1
1–474 were digested with BamHI and AflII restriction
enzymes and ligated such that TgICMAP1
1–474 was replaced
with TgICMAP1
455–1231. pBAD24-6xHis-TgICMAP1
1–474 was
constructed by ligating the 6xHis-TgICMAP1
1–474 EcoRI-HindIII
region from pQE30-6xHis-TgICMAP1
1–474 into the EcoRI and
HindIII sites of pBAD24 (A kind gift from Dr. Pat Foster, Indiana
University, Bloomington).
3. Mammalian cell expression plasmids. pc22-eGFP-
TgICMAP1 was constructed by replacing the eGFP-TubA1
NheI-AflII fragment in pc22-eGFP-TubA1 (a kind gift from Dr.
John Murray, University of Pennsylvania) with the eGFP-
TgICMAP1 NheI-AflII fragment from pmin-eGFP-TgICMAP1
(see above). To construct pc22-eGFP-TgICMAP1
1–474, pc22-
eGFP-TgICMAP1 was digested with HindIII and AflII, filled in
by Klenow fragment, and religated.
Protein expression and purification
1. Expression and purification of 6xHis-eGFP-
TgICMAP1. Single BL21(DE3)pLysS bacterial colonies contain-
ing pQE30-6xHis-eGFP-TgICMAP1 plasmid were grown over-
night in 50 ml LB containing 100 mg/ml of ampicillin, 50 mg/ml
chloramphenicol (LB-amp-cap) at 37uC. Cultures were diluted 1:25
into 750 ml LB-amp-cap until the OD600 reached ,0.6. Cultures
were induced with 1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) and grown overnight (,18 hrs) at 16uC. Cells were then
pelleted at 15,000 rpm for 5 minutes, resuspended in 40 ml of cold
lysis buffer (8 mM Tris-Ac pH 7.5, 3 mM Trisbase, 100 mM KAc,
1 mM MgAc) containing 1% TX-100, 1.2 g of cell lytic express (,1
vial, Cat#C1990, Sigma), 1 mM TAME (Cat#T4626: Sigma) and
1 mM PMSF (Cat#P7626:Sigma), and incubated at 4uC for 15
minutes. Cells were sonicated five times for 30 seconds each with 1
minute cooling between each cycle, then centrifuged at 15,000 rpm
for 10 minutes at 4uC. 0.5 ml of Talon resin (Cat#635501,
Clontech) equilibrated with lysis buffer was then added to the
supernatant and gently mixed at 4uC for 2 hours. The resin was
loaded on a gravity flow column (Cat#635513: Clontech) and then
washed with 30 ml of wash buffer (lysis buffer containing 10 mM
imidazole). Proteins were eluted with 250 ml of elution buffer
(50 mM Tris-Cl pH 7.5, 250 mM imidazole, 300 mM KCl).
Proteins were stored on ice and used within one week of
purification.
2. Expression and purification of recombinant 6xHis-
TgICMAP1
1–474 for antibody production. Single BL21
(DE3)pLysS bacterial colonies containing pBAD24-6xHis-
TgICMAP1
1–474 plasmid were grown and lysed as described
above with the following exceptions. Cultures were grown in LB-
amp-cap containing 0.2% glucose and protein expression was
induced with glucose-free LB-amp-cap containing 0.2% arabinose
for four hours at 37uC [52]. After lysis and centrifugation the
supernatant was discarded and insoluble proteins were solubilized
using 6 M guanidine hydrochloride, 50 mM Hepes (pH 7) and
25 mM DTT (6 M guanidine HCl buffer) at 4uC for 1 hour.
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for 10 minutes at 4uC. 1 ml of Talon resin equilibrated with 6 M
guanidine HCl buffer was then added to the supernatant and
gently mixed at 4uC for 2 hours. The resin was loaded on a gravity
flow column (Cat#635606, Clontech) and then washed with
successively lower amounts of guanidine hydrochloride (5 M, 4 M,
3 M, 2 M, 1 M 0.5 M and 0.25 M containing 50 mM Hepes and
25 mM DTT, pH 7). Proteins were eluted from the beads with
1 ml of elution buffer and the first and second eluates were pooled
together and used to inject rats for the antibody production
(Cocalico Biologicals Inc, Reamstown, PA).
MT binding assays
Recycled bovine tubulin, guanylyl-(a,b)-methylene-diphospho-
nate (GMPcPP) (Jena Scientific, Jena, Germany), and 6xHis-eGFP
were kind gifts from the lab of Claire Walczak (Indiana University,
Bloomington). 10 mM clarified recycled tubulin was incubated
with 0.5 mM final concentration of GMPcPP in BRB80 (80 mM
piperazine-N,N-bix[2-ethanesulfonic acid] (PIPES) pH 6.8, 1 mM
MgCl2, 1 mM EGTA, 1 mM DTT) at 37uC for 30 minutes
[53,54]. MTs were then pelleted at 45,000 rpm for 5 minutes in a
Beckman TLA100 rotor at 30uC and resuspended in BRB80. MTs
were diluted to 2 mM in BRB80 before use. Visual MT binding
assays were performed essentially as described [53]. Reactions
consisted of mixing 2 mM MTs and 1.2 mM 6xHis-eGFP-
TgICMAP1 or 6xHis-eGFP together in a 1:1 ratio and incubating
for 15 minutes at 23uC. The reactions were fixed in 1%
gluteraldehyde for 2 minutes, diluted with BRB80, and spun onto
poly-L-lysine coated coverslips through a 10% (v/v) glycerol/
BRB80 cushion at 14,000 rpm in a Beckman JS13.1 rotor for
45–90 minutes at 20uC. Coverslips were then dehydrated
with 220uC methanol for five minutes and rehydrated with
PBS (140 mM NaCl, 30 mM KCl, 2 mM K-Phosphate, 10 mM
Na-Phosphate) with 0.1% Triton X-100 (TX-100) for 5 minutes.
Finally, slides were blocked with PBS containing 2% BSA for 15
minutes, incubated consecutively with 1:1000 dilution of mouse
anti-tubulin B-5-1-2 and 1:1000 dilution of goat anti-mouse Alexa
568 for 30 minutes each.
Immunofluorescence
HeLa or mouse embryonic fibroblast cells were first fixed and
permeabilized for 2 minutes at 37uC in PHEM buffer (60 mM
PIPES, 28 mM Hepes, 10 mM EGTA, 8 mM MgSO4, pH 7.0)
containing 3.7% (v/v) formaldehyde, 0.1% (v/v) gluteraldehyde,
1% (v/v) TX-100, fixed again in PHEM buffer containing 3.7%
formaldehyde and 0.1% gluteraldehyde for 15 minutes, and then
permeabilized again in PHEM buffer containing 1% TX-100 for
30 minutes. Cells were washed in PBS containing 1 mM MgCl2
(MgPBS) and quenched three times in PBS containing ,10 mg
sodium borohydride dissolved in PBS for two minutes each. Cells
were then blocked in MgPBST (MgPBS, 0.02% (v/v) Tween-20)
containing 2% (v/v) BSA for five minutes, incubated in primary
antibody for 1 hour, washed three times in MgPBST and
subsequently incubated in either goat anti-mouse Alexa 594
(Cat#: A11032, Molecular Probes, Invitrogen) or goat-anti-rat
Alexa 647 (Cat#: A21247, Molecular Probes, Invitrogen) diluted
1:1000 in MgPBS with 2% BSA, or incubated in donkey-anti-rat
X-rhodamine (Cat#: 712-295-153, Jackson ImmunoResearch
Laboratories, Inc, West Grove, PA) diluted 1:500 in MgPBS with
1% BSA for 60 minutes. Primary antibody dilutions were as
follows: mouse anti-tubulin B-5-1-2, 1:1000 (Cat#T6074, Sigma);
mouse anti-acetylated tubulin, 1:400 (Cat#MMS-413R, Cov-
ance); rat anti-tubulin YL1/2 hybridoma supernatant, 1:1 (A kind
gift from Dr. John Murray, University of Pennsylvania); rat anti-
tubulin YL1/2 ascites, 1:800 (Cat#: MCA77G, AbD Serotec,
Raleigh, NC). Coverslips were mounted on slides using ProLong
Gold Antifade Reagent (Cat#P36930, Molecular Probes, Invitro-
gen). All incubations were carried out at room temperature unless
otherwise stated. For methanol fixation, cells were washed three
times at 37uC in PBS, fixed and permealized for 5 minutes in
220uC methanol. Cells were then washed three times in MgPBS.
The rest of the procedure for immunofluorescence was the same as
described above.
For immunolabeling of intracellular parasites, T. gondii growing
in HFF monolayer were fixed in either 3.7% formaldehyde in PBS
for 15 minutes and permeabilized with 0.25% TX-100 in PBS for
15 minutes at room temperature or 220uC methanol for 5
minutes. Cells were blocked with 2% BSA in PBS for 5 minutes at
room temperature and then incubated in primary and subse-
quently secondary antibody solutions for 60 minutes each. Primary
antibody dilutions were as follows: mouse anti-IMC1, 1:1000 (A
kind gift from Dr. Gary Ward, University of Vermont); mouse
anti-tubulin B-5-1-2, 1:1000; rat anti-TgICMAP1, 1:100 (pro-
duced by Cocalico Biological, Inc.). Goat anti-mouse Alexa 568
(Cat#: A11031, Molecular Probes-Invitrogen) and goat anti-rat
Alexa 488 (Cat#: A11006, Molecular Probes-Invitrogen) second-
ary antibodies were used at 1:1000 dilution.
For immunolabeling of extracellular parasites, 1610
7 parasites
were first suspended in PBS containing 5 mM calcium ionophore,
A23187 (Cat#C7522, Sigma), and then spotted onto clean
parafilm and overlayed with poly-lysine coated coverslips for 30
minutes. The purpose for having A23187 in the suspension was to
induce conoid extension, which is calcium dependent. Parasites
were then extracted in 10 mM deoxycholate in PBS for 25
minutes, and fixed in 3.7% formaldehyde in PBS for 15 minutes.
Coverslips were blocked with 2% BSA in PBS for five minutes.
The cells were then incubated for 60 minutes in mouse anti-
tubulin B-5-1-2 diluted 1:1000 and rat anti-TgICMAP1 diluted
1:100 and subsequently in goat anti-rat Alexa 488 and goat anti-
mouse Alexa 568 diluted 1:1000.
MT stability assay in HeLa cells
Untransfected and pc22-eGFP-TgICMAP1 transfected HeLa
cells were treated with 2 mM nocodazole (Cat#M1404, Sigma) in
DMEM with 10% BCS for 4 hours at 37uC and 5% CO2. Slides
were then fixed and processed as described above in the
Immunofluorescence section. 50–100 untransfected control or trans-
fected cells were scored from the same coverslip as either
containing high or low levels of MTs (The levels of MTs were
determined qualitatively. Representative images are shown in
Figure 4C.), and the average percentage of cells containing high
levels of MTs was determined from three independent experi-
ments. Quantification of TgICMAP1 expression level was
performed using SoftWoRx (Applied Precision, Inc). Cells
transfected with pc22-eGFP-TgICMAP1 were assigned to high
or low expression groups using three times the average
fluorescence of untransfected cells as the threshold. Statistical
analysis (Student’s t-test) was performed using GraphPad Prism
version 5.0 and a difference was considered to be significant when
p,0.01.
Light microscopy
3D image stacks were collected at room temperature at
z-increments of 0.3 mm using an Applied Precision Delta Vision
imaging station constructed on an Olympus IX-70 inverted
microscope base. A 1006 oil immersion lens (1.4 NA) and
immersion oil at refractive index 1.518 were used for all the
imaging. Deconvolved images were computed using the point-
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Fluorescent images are maximum intensity projections of
deconvolved 3D stacks. The brightness and contrast of images
used in the final figures were optimized for color prints.
ImmunoGold Labeling
3610
7 RH parasites were first suspended in 5 ml PBS containing
5 mM calcium ionophore, A23187, and then spotted onto clean
parafilm and overlayed with a carbon-film–coated nickel grid for
1 hour in a humid chamber. Parasites were then permeabilized
with 10 mM DOC in PBS for 25 minutes and fixed with 3.7%
formaldehyde in PBS, and washed 365 minutes with PBS,
followed by 10 minutes of blocking in 5% BSA +0.1% (v/v) fish
gelatin. Free aldehyde groups were blocked by incubation with
50 mM glycine in PBS for 15 minutes (pH 7.5) followed by 15
minute incubation with 0.1% (w/v) NaBH4 in PBS. Grids were
washed twice with PBS, blocked again with 5% BSA +0.1% fish
gelatin in PBS for 30 minutes, washed 265 minutes with
incubation buffer (0.8% BSA, 0.1% fish gelatin in PBS plus
10 mM NaN3), incubated for ,2 hours with primary antibody (rat
anti-TgICMAP1), diluted 1:100 in incubation buffer; washed 665
minutes in incubation buffer, inverted on 15 ml drops of secondary
antibody (goat anti–rat IgG-conjugated with ultra-small gold
(EMS Inc Cat#25181)), diluted 1:50 in incubation buffer;
incubated ,19 hours at 4uC, then washed with incubation buffer
as follows: 361 minute, 2610 minutes, 465 minutes, and then
561 minute with PBS. The samples were post-fixed for 5 minutes
with 1% glutaraldehyde in PBS and washed in distilled water 365
minutes. Silver enhancement was carried out using the HQ silver
enhancement kit (Nanoprobes) by floating grids on mixtures of the
initiator, activator, and modulator for 6 minutes in a light-tight
chamber, then washing briefly with distilled water once followed
by 265 minutes washes in distilled water. Grids were negatively
stained using 2% phosphotungstic acid (pH 7.0).
Western blot
5610
6 extracellular parasites were lysed by incubating in 1x
sample buffer (62.5 mM Tris pH 6.8, 2% (w/v) sodium deodeoyl
sulfate, 10% (v/v) glycerol, ,0.5 mg of bromophenol blue)
containing 50 mM DTT at 100uC for 10 minutes. Proteins were
resolved on 4–12% gradient bis-tris gels (Cat#NP0332, Invitro-
gen) at 200 V for 1 hour. Proteins were transferred to poly-
vinylidene fluoride (PVDF) membrane using the XCell
TM blot
module (Cat#EI9051, Invitrogen) per manufacturers instructions.
Western blot was carried out using BM chemiluminescence
Western blotting kit (Cat#1152709001, Roche) per the instruc-
tions of the manufacturer. Washes were carried out in TBS
(20 mM Tris base pH 7.4, 150 mM NaCl) containing 0.1% (v/v)
Tween-20 (Sigma Cat#P7949). Rat anti-TgICMAP1 was diluted
1:250 and mouse-anti-tubulin B-5-1-2 was diluted 1:2,000 in TBS
containing 0.5% (v/v) blocking buffer (Cat#1152709001, Roche).
Goat anti-rat IgG HRP (Cat#NA935V, GE Healthcare, United
Kingdom) was diluted 1:1000 and goat anti-mouse/rabbit HRP
(Cat#1152709001, Roche) was diluted 1:20,000 in TBS contain-
ing 0.5% blocking buffer.
Supporting Information
Table S1 Primer sequences used for the construction of plasmids
used in this paper. Abbreviations: S; sense primer, AS; anti-sense
primer.
Found at: doi:10.1371/journal.pone.0007406.s001 (0.05 MB
DOC)
Figure S1 NcICMAP1 is homologous to TgICMAP1. ClustalW
alignment of TgICMAP1 and NcICMAP1, which share 82%
identity and 89% similarity. Sequence homologous to the coiled-
coil SMC domain is highlighted in red. ‘‘*’’ indicates conserved
amino acids; ‘‘:’’ indicates conserved substitution; ‘‘.’’ indicates
semi-conserved substitution. EuPathDB accession numbers are
TgICMAP1: TgME49_039300, NcICMAP1: Nc_LIV_ 070470.
Found at: doi:10.1371/journal.pone.0007406.s002 (0.74 MB TIF)
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